Scope
Description
NHS National Generic Pharmaceuticals Lenalidomide, Pomalidomide and Thalidomide procurement
Commercial tool
Establishes a framework
Total value (estimated)
- £38,115,172 excluding VAT
- £45,738,206.40 including VAT
Contract dates (estimated)
- 1 June 2026 to 31 May 2027
- Possible extension to 31 May 2029
- 3 years
Main category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
1 February 2026
Procedure
Above or below total value threshold
Above or equal to threshold
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: england.generics@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government